Media and Analyst Coverage

Dimerix in the news following positive Phase 2a trial results in Chronic Kidney Disease

As you may know, Dimerix was pleased to release positive results for our DMX-200 Phase 2a trial in Chronic Kidney Disease (CKD) on 12 July 2017.

You can see that announcement here.

Following the data release, a number of media outlets featured Dimerix’s results.

We have provided a recap below for your interest.


Chanel 9 News, 25 August […]

By | 2017-09-08T13:58:35+00:00 July 28th, 2017|Media and Analyst Coverage|

Video: NDF Research interview on Phase 2a results

In the interview, Kathy Harrison and Associate Professor David Packham, a Principal Investigator in the DMX-200 Phase 2a study and Director of Melbourne Renal Research Group, discusses Dimerix’s Phase 2a trial result of DMX-200 with Stuart Roberts, Senior Analyst with NDF Research.

The full interview is available here.

By | 2017-07-17T08:22:20+00:00 July 14th, 2017|Latest ASX Announcements, Media and Analyst Coverage|